Sandra Lucile Kemptner, PA-C

Sandra Kemptner practices at Golden State Dermatopathology in Walnut Creek, California.

Sandra Kemptner's NPI, 1265710396, was assigned on July 22, 2011. Sandra Kemptner holds California license PA21660.

Sandra Kemptner's primary practice is Golden State Dermatopathology, at 370 N Wiget Ln, Ste 250, Walnut Creek, CA 94598. The practice phone is (925) 278-7592.

Sandra Kemptner's primary practice is Golden State Dermatopathology in Walnut Creek, California. The medical group on file is Golden State Dermatology. Dmand AI also links Sandra Kemptner to 1 more group practice or clinic and 1 medical group, each named with a free account. Sandra Kemptner's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Sandra Kemptner practices, 2 sites in all. Vendor and product names are available with a free account.

Medical is Sandra Kemptner's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Sandra Kemptner is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Sandra Kemptner is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, joint cyst, minor injury to a limb and psoriasis among the conditions Sandra Kemptner treats.

CMS data shows 2,479 Medicare services from Sandra Kemptner across 13 procedure codes in 2024, for 388 Medicare patients. Medicare paid $99,062 for them. Every service was in an office.

CMS counts 388 Medicare patients who saw Sandra Kemptner in 2024. The largest group is 65 to 74, with 190 patients. 75% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Sandra Kemptner's median patient age at 68, with 69% women.

In 2024, Sandra Kemptner wrote 610 Medicare Part D claims for 212 patients. 90% of them were for generic drugs. CMS names the drug for 494 of them, across 13 drugs with 11 or more claims each, at $123,078 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Sandra Kemptner for performance year 2024, reported as part of a group. Sandra Kemptner accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 254 general payments to Sandra Kemptner from 24 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 95% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,266.